Uncrustables tops $1 billion as JM Smucker posts strong Q4

JM Smucker said its Uncrustables brand surpassed $1 billion in annual sales in Q4, adding 3 million new households over the past year. The company reported Q4 earnings of $2.77 per share on $2.27 billion revenue, beating estimates of $2.65 on $2.27 billion, and shares rose over 10% after hours to $112.98. Smucker cited growth in Café Bustelo and pet brands.

Original reporting
Published Jun 11, 2026, 1:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 11, 2026, 1:44 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Uncrustables tops $1 billion as JM Smucker posts strong Q4 — source image
Decision brief

The 30-second read

$SJMBullishMed
01

Why it matters

Traders can connect the earnings beat and after-hours move to concrete brand KPIs (household growth, sequential acceleration, net sales growth) and to a potential margin/price normalization path in coffee as commodity costs moderate.

02

Market read

A single-company earnings print with brand-level growth metrics and a stated pricing/commodity normalization plan provides a tradable catalyst for SJM.

03

What to watch

Coffee price cuts are planned as green-coffee deflates; near-term margin could be pressured even if volumes hold, and spreads promotional ramp-down may mask underlying demand softness.

Relevance 9/10Novelty 6/10Timing: after-hours reaction to Q4 results

Background

The article is a Q4 earnings update for JM Smucker, highlighting brand milestones (Uncrustables >$1B) and coffee/pet food growth, alongside tariff-driven pricing dynamics.

Company-level read

Ticker impact

$SJMBullishHigh confidence
Context

JM Smucker reported better-than-expected Q4 EPS ($2.77) and revenue ($2.27B) plus Uncrustables surpassing $1B, driving a >10% after-hours stock jump.

Expected impact

Bullish near-term bias as investors price continued momentum in Uncrustables/Café Bustelo and potential pricing normalization in coffee.

Evidence & confidence

The article provides specific earnings beats, after-hours reaction, and brand-level growth metrics (Uncrustables +8% sequential; Café Bustelo net sales +39% FY26; coffee net sales +12% Q4) that directly support earnings quality and forward demand.

Market effects

Signals resilience in branded frozen sandwiches, coffee, and pet food despite prior tariff-driven cost pressure; supports the view that pricing power/volume can offset input volatility.

Café Bustelo distribution expansion planned for Central and West Coast could shift regional retail demand and promotional intensity.

Tariff rollbacks and green-coffee moderation imply potential margin tailwind/price normalization dynamics for US coffee brands.

Counterpoint

Spreads and snacks outside Uncrustables are still described as needing work (spreads down; Hostess stabilization ongoing), which could cap multiple expansion if momentum fades.

Key entities

  • JM Smucker

    Reported better-than-expected Q4 results and highlighted Uncrustables milestone plus Café Bustelo and pet food growth.

  • Uncrustables

    Frozen peanut butter and jelly sandwiches; surpassed $1B and grew 8% sequentially in Q4.

  • Café Bustelo

    Coffee portfolio; net coffee sales grew 12% in Q4 and net sales up 39% in fiscal year 2026.

  • Meow Mix / Milk-Bone

    Pet food brands; Meow Mix showed 8% net sales growth in Q4 while Milk-Bone actions aim to return growth.

Related articles

$UTZMed

Family-owned companies have big appetites for US snack M&A

Utz UTZ.N agreed to be taken private by Germany’s Intersnack Group, with Utz’s founding families, in a deal valued at nearly $3 billion, the first U.S. acquisition for Intersnack. The article cites other family-led snack deals including Ferrero’s purchases of WK Kellogg and Power Crunch, and Mars’s $36 billion take-private of Kellanova. It notes valuation multiples and potential targets.

$SJMMed

J.M. Smucker Q4 Earnings Call Highlights

J.M. Smucker said it expects profit improvement in coffee as the commodity environment moderates, while it is cautious about forecasting volume response to lower prices because consumers remain guarded. For fiscal 2027, it expects net sales roughly flat in Q1, with coffee deflation impacting more in Q2+. Uncrustables hit $1B sales; Smucker targets mid-single-digit growth in fiscal 2027. It generated $1.2B free cash flow in 2026, repaying $700M+ debt, and targets at least $1B FCF in 2027 while as

$MRVLMed

Stocks Erase Early Gains as Chipmakers Turn Lower

US stocks pared early gains as chipmakers and software firms fell. Marvell, Qualcomm, ARM and others dropped, while ServiceNow and Salesforce also declined. Treasury yields were pressured by a $58B 3-year auction and stronger May existing home sales. In Europe, Bund and gilt yields fell; swaps price a 100% chance of a 25 bp ECB hike. UNFI slid after Q3 sales missed; Nuvalent surged on a $10.6B GSK buyout.

$SJMMedAI 8/10

Why J.M. Smucker Stock Jumped Today

J.M. Smucker shares rose Tuesday after the company reported fiscal 2026 Q4 results that beat Wall Street. Net sales grew 6% to $2.3B, helped by price increases offsetting volume declines. Adjusted EPS rose 20% to $2.77 vs. $2.64 expected; adjusted operating income rose 14% to $59.7M. Free cash flow increased 42% to $1.2B.

$MUMed

More swings for AI stocks drag Wall Street back on the roller coaster

Wall Street swung as AI-related chip and memory stocks reversed after early gains. The S&P 500 fell 0.3% (7,386.65), the Nasdaq dropped 1% (25,678.82), and the Dow rose 0.2% (50,872.11). Micron slid 1.4% after a 10% drop; it had surged 9.9% Monday. Oil eased (Brent -3% to $91.45) but AI weakness outweighed. GSK agreed to buy Nuvalent for $10.6B, sending Nuvalent up 39.3%.